- November 11, 2020
- Posted by: Jeff Kish
- Categories: Healthcare Research Technologies News, Latest News, Mobile Apps & Serious Games News, Research & Development News, Wearable Design & Manufacturing News
ROCKVILLE, Md.—September 16, 2020—Intelligent Automation, Incorporated (IAI), a technology innovation company, announced today that it has been awarded a contract by the National Institutes of Health’s (NIH) National Cancer Institute (NCI) to develop a platform to collect and integrate data from a variety of wearable sensors to monitor cancer progression and its symptoms.
In this contract, IAI’s solution will collect data from multiple wearable sensors to provide clinicians with objective metrics for assessing patient response to therapeutics, monitoring the side effects of experimental or standard-of-care therapies, and providing ecologically valid clinical endpoints via predictive analytic informatics algorithms. This platform will decrease the assessment burden via increased continuity of physiological measurement sampling in ambulatory settings. With increased patient-clinician engagement, these tools will allow for more precise delivery of cancer care during treatment and remission. Furthermore, IAI’s solution will include a data repository for online research collaboration to support population-based research.
“IAI is grateful to support the NIH/NCI’s efforts to customize wearable healthcare technology for cancer research,” said Vikram Manikonda, President and CEO of IAI.
IAI’s digital healthcare team creates mobile apps and sensors to gather and analyze data from patients outside of the clinical setting. Researchers and practitioners use IAI’s technologies in medical informatics to improve patient outcomes by monitoring patient performance, improving adherence, and providing timely interventions throughout a patient’s healthcare regimen.
IAI is a technology innovation company specializing in providing advanced technology solutions and R&D services to federal agencies and corporations. IAI leverages agile R&D processes, a multi-disciplinary collaborative environment, and a substantial intellectual property portfolio to develop concepts into market-focused products and customer-driven solutions. IAI’s core R&D areas include: AI & Advanced Computing; Autonomy & Robotics; Healthcare Research Technologies; Modeling, Simulation & Visualization; Networks & Cyber Security; and Radar, Communications & Sensors. For more information about IAI, please visit www.i-a-i.com.